Antipsychotic treatment for bipolar disorder in the pediatric population

Research output: Contribution to journalArticle

Abstract

The phenomenology of bipolar disorder in the pediatric population is different from that seen in adults. This can present a major obstacle in the accurate diagnosis of the illness and may also hinder the initiation of appropriate treatment. Historically, the mood stabilizers lithium, divalproex, and carbamazepine have been studied in the pediatric population with varying degrees of methodologic rigor. Recently, a body of literature has grown regarding the use of atypical antipsychotics for the treatment of pediatric bipolar disorder. Atypical antipsychotics have shown promise in the treatment of young people who present with symptoms of mania, but long-term adverse effects such as weight gain and tardive dyskinesia might be a concern with these agents and may be particularly worrisome. Children and adolescents tend to be more susceptible to antipsychotic-related adverse effects than adults; therefore, the risk of adverse effects must be balanced against the potential benefits associated with these agents.

Original languageEnglish (US)
JournalAdvanced Studies in Medicine
Volume4
Issue number10 F
StatePublished - Dec 2004
Externally publishedYes

Fingerprint

Bipolar Disorder
Antipsychotic Agents
Pediatrics
Population
Carbamazepine
Valproic Acid
Lithium
Weight Gain
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Antipsychotic treatment for bipolar disorder in the pediatric population. / Findling, Robert L.

In: Advanced Studies in Medicine, Vol. 4, No. 10 F, 12.2004.

Research output: Contribution to journalArticle

@article{965561897aab4727b67db272f34a05f7,
title = "Antipsychotic treatment for bipolar disorder in the pediatric population",
abstract = "The phenomenology of bipolar disorder in the pediatric population is different from that seen in adults. This can present a major obstacle in the accurate diagnosis of the illness and may also hinder the initiation of appropriate treatment. Historically, the mood stabilizers lithium, divalproex, and carbamazepine have been studied in the pediatric population with varying degrees of methodologic rigor. Recently, a body of literature has grown regarding the use of atypical antipsychotics for the treatment of pediatric bipolar disorder. Atypical antipsychotics have shown promise in the treatment of young people who present with symptoms of mania, but long-term adverse effects such as weight gain and tardive dyskinesia might be a concern with these agents and may be particularly worrisome. Children and adolescents tend to be more susceptible to antipsychotic-related adverse effects than adults; therefore, the risk of adverse effects must be balanced against the potential benefits associated with these agents.",
author = "Findling, {Robert L}",
year = "2004",
month = "12",
language = "English (US)",
volume = "4",
journal = "Advanced Studies in Medicine",
issn = "1530-3004",
publisher = "Galen Publishing LLC",
number = "10 F",

}

TY - JOUR

T1 - Antipsychotic treatment for bipolar disorder in the pediatric population

AU - Findling, Robert L

PY - 2004/12

Y1 - 2004/12

N2 - The phenomenology of bipolar disorder in the pediatric population is different from that seen in adults. This can present a major obstacle in the accurate diagnosis of the illness and may also hinder the initiation of appropriate treatment. Historically, the mood stabilizers lithium, divalproex, and carbamazepine have been studied in the pediatric population with varying degrees of methodologic rigor. Recently, a body of literature has grown regarding the use of atypical antipsychotics for the treatment of pediatric bipolar disorder. Atypical antipsychotics have shown promise in the treatment of young people who present with symptoms of mania, but long-term adverse effects such as weight gain and tardive dyskinesia might be a concern with these agents and may be particularly worrisome. Children and adolescents tend to be more susceptible to antipsychotic-related adverse effects than adults; therefore, the risk of adverse effects must be balanced against the potential benefits associated with these agents.

AB - The phenomenology of bipolar disorder in the pediatric population is different from that seen in adults. This can present a major obstacle in the accurate diagnosis of the illness and may also hinder the initiation of appropriate treatment. Historically, the mood stabilizers lithium, divalproex, and carbamazepine have been studied in the pediatric population with varying degrees of methodologic rigor. Recently, a body of literature has grown regarding the use of atypical antipsychotics for the treatment of pediatric bipolar disorder. Atypical antipsychotics have shown promise in the treatment of young people who present with symptoms of mania, but long-term adverse effects such as weight gain and tardive dyskinesia might be a concern with these agents and may be particularly worrisome. Children and adolescents tend to be more susceptible to antipsychotic-related adverse effects than adults; therefore, the risk of adverse effects must be balanced against the potential benefits associated with these agents.

UR - http://www.scopus.com/inward/record.url?scp=11144348641&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=11144348641&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:11144348641

VL - 4

JO - Advanced Studies in Medicine

JF - Advanced Studies in Medicine

SN - 1530-3004

IS - 10 F

ER -